Zempilo, Ukulungiselela
Inkcazo yezilwanyana 'Amiksin': imiyalelo yokusetyenziswa kunye nemiphumo emibi
"I-Amiksin" isichengululo se-anti-virus esenza ukuba i-interferon iqulunqwe. Ukusebenza kwayo ephakamileyo kuphawulwe ngexesha lokunyangwa kwezifo ezininzi zentsholongwane, njenge-herpes, i-hepatitis, i-ARVI kunye nomkhuhlane kuquka. Indlela yokuhlaselwa kwe-antiviral yokulungiselela "imiyalelo ye-Amiksin" yokusetyenziswa ibophezela ekukhuselweni kwamaseli anentsholongwane yeeprotheni ezithile. Isiphumo salolu msebenzi kukunyanzeliswa komsebenzi wokuzala wee-virus.
"Amiksin" yindlela yokulwa ne-antibiotiki kunye nefuthe eliqhamo le-alpha, beta kunye ne- gamma interferons emzimbeni. Iinkqubo eziphambili ezithatha ukuphendula ukuveliswa kwe-Amixin ukuveliswa kwe-interferon eyenziwa yi-neutrophils, i-T-lymphocytes, amaseli e- intestinal epithelial kunye ne-hepatocytes. Inani eliphakamileyo le-interferon emva kokuthatha iziyobisi ligcinwa ngexesha elide ukusuka kwiiyure ezingama-4 ukuya kuma-24, ukulandelelana kwemveliso yayo kunokubonakaliswa ngethambo lomathumbu-isibindi-plasma.
I-Impunomodulatory effect of the drug "Amiksin" imiyalelo yokusetyenziswa ichaza ukuvuselelwa kweeseli zentsholongwane yomnxeba, ukwanda kwemveliso ye-antibody (kuxhomekeke kumyinge), ukunciphisa ubunzima be-immunosuppression.
Into esebenzayo yesicatshulwa esithi "Amiksin" - i-tiloron, emva kokulawulwa komlomo ichithwa kwi-digestive tract, isixa sokungabikho kwezidakamizwa ngu-60%. Kukho ukungena ngokukhawuleza kwesilwanyana kwizicubu, izifo zomzimba, malunga neepesenti ezingama-80 ezibophelela kwiiprotheni zegazi le-plasma.
Ngenxa yokuba isicatshulwa esisebenzayo sesilwanyana asitshintshi ibe yinye into eyenziwa yi-biological, i-excinated urine (9%) kunye nemfesi (70%) ingatshintshi emva kweeyure ezingama-48.
Xa kwenzeka umonakalo wentsholongwane emzimbeni, kubalulekile ukuba uqale ukuthatha isilwanyana "Amiksin", umyalelo wokusetyenziswa ubonisa ezi zilandelayo zibonakaliso:
Usulelo lweHerpes ;
- SARS, umkhuhlane. Isetyenziswe njenge-arhente okanye i-prophylactic agent;
- i- viral hepatitis A, B, C;
- isifo sofuba se-pulmonary (kwisifo esiyinkimbinkimbi);
- encephalomyelitis, isifo-esichaphazelayo okanye isifo segciwane (kwisifo esiyinkimbinkimbi);
- I- Chlamydia (urogenital okanye ukuphefumula);
Abantwana abaneminyaka engama-7 yesicatshulwa "imfundiso ye-Amiksin" yokusetyenziswa iyancoma njengonyango kunye nokukhusela i-ARVI kunye nomkhuhlane.
Iindlela zokwenza isicelo kunye nokulingana kweziyobisi kuxhomekeke kuhlobo lokusuleleka kwintsholongwane, ubudala besigulane kunye nesantya sesifo. Thatha inkunkuma ngaphakathi ngaphakathi emva kokutya. I-dose ephakanyisiweyo kwiimeko eziqhelekileyo yi-125-250 mg kwiintsuku ezimbini zokuqala, ngoko-tablet ye-iziza zonke iintsuku ezimbini.
Ukuvela kweminye imiphumo ngexesha lolawulo lwezilwanyana "Amiksin" imiyalelo yokusetyenziswa ichaza inkqubo yokutya. Iimpawu zokusabalala zivela kwiimeko ezizimeleyo. Ngexesha lokumkela isilwanyana "Amiksin" nemiphumo echaphazelekayo ikwaqatshelwa ngendlela ye-short-term chill kunye neempembelelo. Ukusetyenziswa kweziyobisi kunqatshelwe kwabesetyhini abakhulelweyo, abantwana abangaphantsi kweeminyaka ezisixhenxe kunye nezigulane ezinobungcali obukhethekileyo kwi tyrolon. Ngethuba lokulahlwa, ukuba kukho isidingo esichukumisayo sokuthabatha iziyobisi, yeka ukondla umntwana.
Okwangoku, uphando lwezokwelapha aluzange luqhube uphando kwiziganeko zokudlula ngokwexesha kunye ne "Amiksin", imiyalelo yokusetyenziswa ayibonakali nemiyalelo ekhethekileyo ngokuphathelele ukudibanisa neyeza kunye namanye amayeza. Ngokuchasene noko, unyango lunokudibaniswa namanye ama-antibiotics, ama-anti-infectious agents, kodwa kulo mzekelo, kubalulekile ukubonisana neengcali.
"Amiksin" ikhiqizwa kwiipilisi ezijikelezileyo ze-6 okanye 10 ezipakethe. Ubomi bekhefu lonyango lukhawulelwe kwiminyaka emithathu. Ukuba ithebhulethi eli-1 iqulethe i-60 mg yezinto ezisetyenziswayo, inikwe ikhemistri ngaphandle komrhumo, kwaye isigqirha segqirha siyadingeka ukuba isasaze iyeza eline 125 mg yexabiso.
Similar articles
Trending Now